489 results on '"Thota, Prashanthi N."'
Search Results
2. Neoplastic Progression Risk in Females With Barrett’s Esophagus: A Systematic Review and Meta-Analysis of Individual Patient Data
3. Neoplastic Progression of Barrett’s Esophagus Among Organ Transplant Recipients: a Retrospective Cohort Study
4. Impact of the coronavirus disease 2019 pandemic on trends and healthcare disparities in use of screening colonoscopy and adenoma detection rates
5. Efficacy of peroral endoscopic myotomy for the treatment of functional esophagogastric junction outflow obstruction
6. A Tissue Systems Pathology Test Outperforms the Standard of Care Variables in Predicting Progression in Patients with Barrett’s Esophagus
7. Prediction of neoplastic progression in Barrett’s esophagus using nanoscale nuclear architecture mapping: a pilot study
8. Wide-area transepithelial sampling for dysplasia detection in Barrett’s esophagus: a systematic review and meta-analysis
9. Age of diagnosis in familial Barrett’s associated neoplasia
10. Peroral endoscopic myotomy is equally safe and highly effective treatment option in achalasia patients with both lower and higher ASA classification status
11. Massively Parallel Sequencing of Esophageal Brushings Enables an Aneuploidy-Based Classification of Patients With Barrett’s Esophagus
12. Allaying uncertainty in diagnosing buried Barrett's esophagus
13. Clinical Success and Correlation of Eckardt Scores with Barium Esophagram After Peroral Endoscopic Myotomy in Achalasia
14. Multicenter, Prospective Trial of Nonendoscopic Biomarker-Driven Detection of Barrett's Esophagus and Esophageal Adenocarcinoma.
15. Peroral Pyloromytomy is Effective and Safe for Postsurgical Gastroparesis
16. Peroral endoscopic myotomy is highly effective for achalasia patients with recurrent symptoms after pneumatic dilatation
17. Changes in esophageal physiology after paraesophageal hernia repair and Collis gastroplasty
18. Trends and risk factors for 30-day readmissions in patients with acute cholangitis: analysis from the national readmission database
19. Peroral Endoscopic Myotomy Is Effective for Patients With Achalasia and Normal Lower-Esophageal Sphincter Relaxation Pressures
20. Lower Annual Rate of Progression of Short-Segment vs Long-Segment Barrett’s Esophagus to Esophageal Adenocarcinoma
21. Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma
22. Reintervention After Heller Myotomy for Achalasia: Is It Inevitable?
23. Value of routine timed barium esophagram follow-up in achalasia after myotomy
24. Pancreatitis due to Clomiphene Citrate-Induced Hypertriglyceridemia: A Case Report and Literature Review
25. Proposal of high-risk adenoma detection rate as an impactful, complementary quality indicator of colonoscopy
26. Peroral endoscopic myotomy leads to higher rates of abnormal esophageal acid exposure than laparoscopic Heller myotomy in achalasia
27. Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy
28. Correction to: Trends and risk factors for 30‑day readmissions in patients with acute cholangitis: analysis from the national readmission database
29. Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study.
30. Quality of Colonoscopy: A Comparison Between Gastroenterologists and Nongastroenterologists
31. Obesity Does Not Impact Outcomes or Rates of Gastroesophageal Reflux After Peroral Endoscopic Myotomy in Achalasia
32. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett’s Esophagus with Dysplasia or Intramucosal Cancer
33. Temporal trends in utilization and outcomes of endoscopic retrograde cholangiopancreatography in acute cholangitis due to choledocholithiasis from 1998 to 2012
34. Post-ablation lymphocytic esophagitis in Barrett esophagus with high grade dysplasia or intramucosal carcinoma
35. Adenoma detection rate in high-risk patients differs from that in average-risk patients
36. Clinical Outcomes Based on the Timing of Appearance of Visible Lesions in Barrett’s Esophagus During Endoscopic Eradication Therapy
37. Hospital Utilization in Patients With Gastric Cancer and Factors Affecting In-Hospital Mortality, Length of Stay, and Costs
38. Endoscopic Treatments of GERD
39. NON-ENDOSCOPIC ESOPHAGEAL SAMPLING DEVICE AND BIOMARKER PANEL FOR DETECTION OF BARRETT’S ESOPHAGUS (BE) AND ESOPHAGEAL ADENOCARCINOMA (EAC)
40. Risk Stratification of Patients With Barrett’s Esophagus and Low-grade Dysplasia or Indefinite for Dysplasia
41. Polypectomy Rate: A Surrogate for Adenoma Detection Rate Varies by Colon Segment, Gender, and Endoscopist
42. Outcomes Associated With Timing of ERCP in Acute Cholangitis Secondary to Choledocholithiasis
43. Aspirin: the miracle drug?
44. Correlation between endoscopic forceps biopsies and endoscopic mucosal resection with endoscopic ultrasound in patients with Barrett’s esophagus with high-grade dysplasia and early cancer
45. Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy
46. Serum 25-Hydroxyvitamin D Levels and the Risk of Dysplasia and Esophageal Adenocarcinoma in Patients with Barrett’s Esophagus
47. Synchronous or Metachronous Occurrence of Lesions of Different Histologic Types in Patients With Esophageal Cancer
48. Lack of incremental effect of histamine receptor antagonists over proton pump inhibitors on the risk of neoplastic progression in patients with Barrettʼs esophagus: a cohort study
49. Adenoma detection at colonoscopy by polypectomy in withdrawal only versus both insertion and withdrawal: a randomized controlled trial
50. Creation of a second submucosal tunnel enabled successful per-oral endoscopic myotomy (POEM)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.